44 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design and synthesis of new 2-anilinoquinolines bearing N-methylpicolinamide moiety as potential antiproliferative agents.
Korea Institute of Science and Technology
Identification of type II inhibitors targeting BRAF using privileged pharmacophores.
Shanghai Institute of Pharmaceutical Industry
Selective inhibitors of the mutant B-Raf pathway: discovery of a potent and orally bioavailable aminoisoquinoline.
Amgen
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF).
The Institute of Cancer Research
Design and Synthesis of Orally Bioavailable Benzimidazoles as Raf Kinase Inhibitors.
Novartis
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity.
Plexxikon